Fish & Richardson and Principal Michael Kane Recognized in 2025 LMG Life Sciences  Americas Awards 

Fish & Richardson is proud to be named Inter Partes Review Firm of the Year in the 2025 LMG Life Sciences Americas Awards, which honor firms and practitioners across the United States, Canada, and Brazil for their exemplary work in the life sciences over the past year. In addition, Principal Michael Kane has been recognized as Post-Grant Proceedings Attorney of the Year.

A highly regarded intellectual property litigator, Kane represents industry-leading companies in patent litigation, post-grant proceedings, and appeals. He focuses his practice on complex patent litigation and post-grant strategy, particularly pharmaceutical matters, and he regularly represents high-profile clients in Hatch-Waxman litigation and matters involving biotechnology and medical devices. Kane has appeared in 135+ petitions, successfully representing both petitioners and patent owners at the Patent Trial and Appeal Board in life sciences and medical device cases.

The world's most innovative life sciences companies, academic institutions, and research organizations trust Fish's Life Sciences Industry Team — with its more than 115 attorneys and technical specialists who hold degrees related to biology, chemistry, or genetic engineering, including over 50 attorneys with Ph.D.s — to handle their most important and technically sophisticated work. Fish's litigation practice is known for its ability to handle massive, high-profile patent disputes requiring extensive global litigation coordination, and the firm is a leader in Hatch-Waxman litigation for branded pharmaceutical companies.

Winners of this year’s LMG Life Sciences Americas Awards were honored at a ceremony on September 4, 2025.